<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedBookArticle><BookDocument><PMID Version="1">34662037</PMID><ArticleIdList><ArticleId IdType="bookaccession">NBK574523</ArticleId></ArticleIdList><Book><Publisher><PublisherName>StatPearls Publishing</PublisherName><PublisherLocation>Treasure Island (FL)</PublisherLocation></Publisher><BookTitle book="statpearls">StatPearls</BookTitle><PubDate><Year>2022</Year><Month>01</Month></PubDate><BeginningDate><Year>2022</Year><Month>01</Month></BeginningDate><Medium>Internet</Medium></Book><ArticleTitle book="statpearls" part="article-137409">Botulinum Toxin Treatment Of The Upper Face</ArticleTitle><Language>eng</Language><AuthorList Type="authors" CompleteYN="Y"><Author ValidYN="Y"><LastName>Biello</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tripler Army Medical Center</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oney</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Tripler Army Medical Center</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Bovey</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Tripler Army Medical Center</Affiliation></AffiliationInfo></Author></AuthorList><PublicationType UI="D000072643">Study Guide</PublicationType><Abstract><AbstractText>Botulinum toxin injection is commonly performed to chemically denervate certain muscles of facial expression for the purposes of facial rejuvenation and anti-aging. Facial rhytids, or "wrinkles," result from repeated contracture of the muscle underlying the facial skin, which over time causes atrophy of the overlying dermis and pleating of the skin. Selective chemodenervation of facial muscles allows for targeted treatment of dynamic rhytids, particularly in the upper face, and also allows for manipulation of eyebrow position and correction of asymmetries. Muscular targets of botulinum toxin in the upper face include the orbicularis oculi, procerus, corrugator supercilii, and frontalis muscles.  Botulinum toxin prevents acetylcholine release at the presynaptic nerve terminal, blocking neurotransmission. Effects usually take up to 2 days to appear, with maximal effect in 1 week to 1 month and last up to 3 to 4 months. Repeated injections of botulinum toxin may cause muscular atrophy in the injected regions, thereby extending the duration of effects. In addition, a retrospective study of 945 patients receiving at least 3 consecutive treatments showed no loss of effect with repeated treatments. After five treatment cycles, patients and providers both rated satisfaction outcomes higher than after the first cycle. Botulinum toxin is created by fermentation of the bacteria <i>Clostridium botulinum</i>. Botulinum toxin has 7 serotypes from A-G; however, types A and B are practically used for cosmetic applications. Serotype A exists in three formulations to include onabotulinumtoxinA, abobotulinumtoxinA, and incobotulinumtoxinA. Serotype B exists in one formulation, rimabotulinumtoxinB. RimabotulinumtoxinB is notable for having the most rapid time to onset; however, it also has the greatest area of diffusion and shortest duration of effect. Its acidic pH (5.5-6.5) also increases the discomfort of an injection. Serotype A botulinum toxins, conversely, have a longer onset to action and longer duration of effect. AbobotulinumtoxinA has a greater spread effect than onabotulinumtoxinA and incobotulinumtoxinA, and therefore dose ratios vary. In cosmetic practice, a typical dose ratio is 2.5 to 1 to 1 (abobotulinumtoxinA: onabotulinumtoxinA: incobotulinumtoxinA).</AbstractText><CopyrightInformation>Copyright © 2022, StatPearls Publishing LLC.</CopyrightInformation></Abstract><Sections><Section><SectionTitle book="statpearls" part="article-137409" sec="article-137409.s1">Continuing Education Activity</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-137409" sec="article-137409.s2">Introduction</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-137409" sec="article-137409.s3">Anatomy and Physiology</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-137409" sec="article-137409.s4">Indications</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-137409" sec="article-137409.s5">Contraindications</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-137409" sec="article-137409.s6">Equipment</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-137409" sec="article-137409.s7">Preparation</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-137409" sec="article-137409.s8">Technique</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-137409" sec="article-137409.s9">Complications</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-137409" sec="article-137409.s10">Clinical Significance</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-137409" sec="article-137409.s11">Enhancing Healthcare Team Outcomes</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-137409" sec="article-137409.s12">Review Questions</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-137409" sec="article-137409.s13">References</SectionTitle></Section></Sections><ContributionDate><Year>2022</Year><Month>4</Month><Day>30</Day></ContributionDate><ReferenceList><Reference><Citation>Small R. Botulinum toxin injection for facial wrinkles. Am Fam Physician. 2014 Aug 01;90(3):168-75.</Citation><ArticleIdList><ArticleId IdType="pubmed">25077722</ArticleId></ArticleIdList></Reference><Reference><Citation>Rzany B, Dill-Müller D, Grablowitz D, Heckmann M, Caird D, German-Austrian Retrospective Study Group  Repeated botulinum toxin A injections for the treatment of lines in the upper face: a retrospective study of 4,103 treatments in 945 patients. Dermatol Surg. 2007 Jan;33(1 Spec No.):S18-25.</Citation><ArticleIdList><ArticleId IdType="pubmed">17241409</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers A. Botulinum toxin type A: history and current cosmetic use in the upper face. Dis Mon. 2002 May;48(5):299-322.</Citation><ArticleIdList><ArticleId IdType="pubmed">12195262</ArticleId></ArticleIdList></Reference><Reference><Citation>Vartanian AJ, Dayan SH. Complications of botulinum toxin A use in facial rejuvenation. Facial Plast Surg Clin North Am. 2005 Feb;13(1):1-10.</Citation><ArticleIdList><ArticleId IdType="pubmed">15519923</ArticleId></ArticleIdList></Reference><Reference><Citation>Padda IS, Tadi P.  StatPearls [Internet] StatPearls Publishing; Treasure Island (FL): 2021. Nov 25, Botulinum Toxin.</Citation><ArticleIdList><ArticleId IdType="pubmed">32491319</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker TJ, Dayan SH. Comparison and overview of currently available neurotoxins. J Clin Aesthet Dermatol. 2014 Feb;7(2):31-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3935649</ArticleId><ArticleId IdType="pubmed">24587850</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan JB. Consideration of Muscle Depth for Botulinum Toxin Injections: A Three-Dimensional Approach. Plast Surg Nurs. 2017 Jan/Mar;37(1):32-38.</Citation><ArticleIdList><ArticleId IdType="pubmed">28244963</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlager S, Kostunov J, Henn D, Stark BG, Iblher N. A 3D Morphometrical Evaluation of Brow Position After Standardized Botulinum Toxin A Treatment of the Forehead and Glabella. Aesthet Surg J. 2019 Apr 08;39(5):553-564.</Citation><ArticleIdList><ArticleId IdType="pubmed">30124769</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogli A. [Orbicularis oculi muscle and crow's feet. Pathogenesis and surgical approach]. Ann Chir Plast Esthet. 1992 Oct;37(5):510-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">1307180</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen AH, Frankel AS. Altering brow contour with botulinum toxin. Facial Plast Surg Clin North Am. 2003 Nov;11(4):457-64.</Citation><ArticleIdList><ArticleId IdType="pubmed">15062250</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M, Wang SM.  StatPearls [Internet] StatPearls Publishing; Treasure Island (FL): 2021. Aug 11, Anatomy, Head and Neck, Eye Corrugator Muscle.</Citation><ArticleIdList><ArticleId IdType="pubmed">31194420</ArticleId></ArticleIdList></Reference><Reference><Citation>Loos BM, Maas CS. Relevant anatomy for botulinum toxin facial rejuvenation. Facial Plast Surg Clin North Am. 2003 Nov;11(4):439-43.</Citation><ArticleIdList><ArticleId IdType="pubmed">15062247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenc ZP, Smith S, Nestor M, Nelson D, Moradi A. Understanding the functional anatomy of the frontalis and glabellar complex for optimal aesthetic botulinum toxin type A therapy. Aesthetic Plast Surg. 2013 Oct;37(5):975-83.</Citation><ArticleIdList><ArticleId IdType="pubmed">23846022</ArticleId></ArticleIdList></Reference><Reference><Citation>Anido J, Arenas D, Arruabarrena C, Domínguez-Gil A, Fajardo C, Mira M, Murillo J, Ribé N, Rivera H, Ruiz Del Cueto S, Silvestre H, Tirado M. Tailored botulinum toxin type A injections in aesthetic medicine: consensus panel recommendations for treating the forehead based on individual facial anatomy and muscle tone. Clin Cosmet Investig Dermatol. 2017;10:413-421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5655032</ArticleId><ArticleId IdType="pubmed">29089780</ArticleId></ArticleIdList></Reference><Reference><Citation>Heydenrych I. The Treatment of Facial Asymmetry with Botulinum Toxin: Current Concepts, Guidelines, and Future Trends. Indian J Plast Surg. 2020 Aug;53(2):219-229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7458832</ArticleId><ArticleId IdType="pubmed">32884188</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos JI, Swensen P, Glasgow LA. Potentiation of Clostridium botulinum toxin aminoglycoside antibiotics: clinical and laboratory observations. Pediatrics. 1981 Jul;68(1):50-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">7243509</ArticleId></ArticleIdList></Reference><Reference><Citation>Frevert J. Xeomin is free from complexing proteins. Toxicon. 2009 Oct;54(5):697-701.</Citation><ArticleIdList><ArticleId IdType="pubmed">19292989</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam M, Bolotin D, Carruthers J, Hexsel D, Lawrence N, Minkis K, Ross EV. Consensus statement regarding storage and reuse of previously reconstituted neuromodulators. Dermatol Surg. 2015 Mar;41(3):321-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25705950</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeliw P, Preechawai P, Aui-aree N. Evaluating the effects of ice application on patient comfort before and after botulinum toxin type A injections. J Med Assoc Thai. 2010 Oct;93(10):1200-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">20973324</ArticleId></ArticleIdList></Reference><Reference><Citation>Söylev MF, Koçak N, Kuvaki B, Ozkan SB, Kir E. Anesthesia with EMLA cream for botulinum A toxin injection into eyelids. Ophthalmologica. 2002 Sep-Oct;216(5):355-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12424403</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma P, Czyz CN, Wulc AE. Investigating the efficacy of vibration anesthesia to reduce pain from cosmetic botulinum toxin injections. Aesthet Surg J. 2011 Nov;31(8):966-71.</Citation><ArticleIdList><ArticleId IdType="pubmed">22001341</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan JB. Consideration of Muscle Depth for Botulinum Toxin Injections: A Three-Dimensional Approach. Plast Surg Nurs. 2019 Apr/Jun;39(2):52-58.</Citation><ArticleIdList><ArticleId IdType="pubmed">31136559</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaram H, Signorini M, Liew S, Trindade de Almeida AR, Wu Y, Vieira Braz A, Fagien S, Goodman GJ, Monheit G, Raspaldo H, Global Aesthetics Consensus Group  Global Aesthetics Consensus: Botulinum Toxin Type A--Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Complications. Plast Reconstr Surg. 2016 Mar;137(3):518e-529e.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5242214</ArticleId><ArticleId IdType="pubmed">26910696</ArticleId></ArticleIdList></Reference><Reference><Citation>King M. The Management of Bruising following Nonsurgical Cosmetic Treatment. J Clin Aesthet Dermatol. 2017 Feb;10(2):E1-E4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5367875</ArticleId><ArticleId IdType="pubmed">28367264</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijemanne S, Vijayakumar D, Jankovic J. Apraclonidine in the treatment of ptosis. J Neurol Sci. 2017 May 15;376:129-132.</Citation><ArticleIdList><ArticleId IdType="pubmed">28431598</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson JJ. Balanced botox chemodenervation of the upper face: symmetry in motion. Semin Plast Surg. 2007 Feb;21(1):47-53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2884826</ArticleId><ArticleId IdType="pubmed">20567657</ArticleId></ArticleIdList></Reference><Reference><Citation>The Aesthetic Society's Cosmetic Surgery National Data Bank: Statistics 2019. Aesthet Surg J. 2020 Jun 15;40(Suppl 1):1-26.</Citation><ArticleIdList><ArticleId IdType="pubmed">32542351</ArticleId></ArticleIdList></Reference><Reference><Citation>Makunts T, Wollmer MA, Abagyan R. Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites. Sci Rep. 2020 Jul 30;10(1):12851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7393507</ArticleId><ArticleId IdType="pubmed">32732918</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair AG, Santhanam A. Clinical Photography for Periorbital and Facial Aesthetic Practice. J Cutan Aesthet Surg. 2016 Apr-Jun;9(2):115-21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4924408</ArticleId><ArticleId IdType="pubmed">27398013</ArticleId></ArticleIdList></Reference><Reference><Citation>Loron AM, Ghaffari A, Poursafargholi N. Personality Disorders among Individuals Seeking Cosmetic Botulinum Toxin Type A (BoNTA) Injection, a Cross-Sectional Study. Eurasian J Med. 2018 Oct;50(3):164-167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6263231</ArticleId><ArticleId IdType="pubmed">30515036</ArticleId></ArticleIdList></Reference></ReferenceList></BookDocument><PubmedBookData><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34662037</ArticleId></ArticleIdList></PubmedBookData></PubmedBookArticle></PubmedArticleSet>
